表紙
市場調查報告書

分子檢驗用控制 (準確度管理物質)的全球市場分析、預測 (∼2024年):非依賴性控制、設備專用控制 (DNA定序等)

Molecular Quality Controls Market by Product (Independent, Instrument Specific (DNA Sequencing)), Analyte Type (Single Analyte, Multianalyte), Application (Infectious Diseases), End User (IVD Manufacturers, Research Institute) - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 787040
出版日期 內容資訊 英文 126 Pages
訂單完成後即時交付
價格
分子檢驗用控制 (準確度管理物質)的全球市場分析、預測 (∼2024年):非依賴性控制、設備專用控制 (DNA定序等) Molecular Quality Controls Market by Product (Independent, Instrument Specific (DNA Sequencing)), Analyte Type (Single Analyte, Multianalyte), Application (Infectious Diseases), End User (IVD Manufacturers, Research Institute) - Global Forecast to 2024
出版日期: 2019年02月07日內容資訊: 英文 126 Pages
簡介

分子檢驗用控制 (準確度管理物質)的市場在預測期間內預計以10.2%的年複合成長率發展,從2018年的1億3200萬美元,成長到2024年2億3700萬美元的規模。第三方準確度管理物質的引進擴大,認證臨床實驗室數的增加,外部準確度管理支援的需求擴大等要素促進該市場的成長。可是同時,對流程的高成本性,醫院、實驗室的預算上的限制,分子檢驗的不利償付方案等要素成為該市場的進一步成長的障礙。

本報告提供全球分子檢驗用控制 (準確度管理物質)的市場調查,市場及產品概要,市場成長的各種影響因素及市場機會分析,各產品類型、分析對象區分、用途、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 簡介
  • 市場動態
    • 成長推動因素
    • 阻礙成長要素
    • 市場機會
    • 課題

第6章 分子檢驗用控制市場分析、預測:各產品類型

  • 簡介
  • 非依賴性控制
  • 設備專用控制
    • PCR
    • DNA定序&NGS
    • 其他

第7章 分子檢驗用控制市場分析、預測:各分析對象

  • 簡介
  • 單獨對象
  • 複數對象

第8章 分子檢驗用控制市場分析、預測:各用途

  • 簡介
  • 感染疾病
  • 癌症
  • 遺傳基因檢驗
  • 其他

第9章 分子檢驗用控制市場分析、預測:各終端用戶

  • 簡介
  • 臨床實驗室
  • 醫院
  • IVD製造商、CRO
  • 學術&研究機關
  • 其他

第10章 分子檢驗用控制市場分析、預測:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
  • 亞太地區
  • 其他地區

第11章 競爭環境

  • 市場概要
  • 市場排行榜
  • 競爭基準
    • 產品系列
    • 事業策略

第12章 企業簡介

  • SERACARE LIFE SCIENCES INC.
  • THERMO FISHER SCIENTIFIC
  • BIO-RAD LABORATORIES
  • MICROBIOLOGICS INC.
  • ZEPTOMETRIX
  • ROCHE DIAGNOSTICS
  • ABBOTT LABORATORIES
  • QUIDEL
  • QNOSTICS
  • MAINE MOLECULAR QUALITY CONTROLS INC.

第13章 附錄

目錄
Product Code: MD 6900

"The rising adoption of third-party quality controls is expected to drive the overall growth of the molecular quality controls market."

The molecular quality controls market is expected to grow from USD 132 million in 2018 to USD 237 million by 2024, at a CAGR of 10.2% during the forecast period. The molecular quality controls market is driven primarily by the rising adoption of third-party quality controls, increasing number of accredited clinical laboratories, and the rising demand for external quality assessment support. However, the high costs involved in the quality control process, budget constraints in hospitals and laboratories, and the unfavorable reimbursement scenario for molecular tests are expected to restrain the growth of this market during the forecast period.

"The infectious diseases segment held the largest share of the molecular controls market in 2018."

Based on application, the molecular controls market is divided into four major segments-infectious diseases, oncology, genetic tests, and other applications. The infectious diseases segment accounted for the largest share of the molecular controls market in 2018. The large share of this segment is attributed to the development of advanced assays for different infectious diseases, significant increase in the prevalence of infectious diseases, and the rising awareness about the effective use of MDx technologies or products to control the occurrence and spread of infectious diseases.

"Asia Pacific projected to grow at the highest CAGR during the forecast period."

The Asia Pacific is projected to record the highest growth rate in the molecular quality controls market during the forecast period. The presence of emerging economies such as China and India and the significant demand for high-quality and accurate diagnostic tests from the large patient population in this region are the major factors supporting the growth of the Asia Pacific molecular controls market.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the molecular quality controls market.

  • By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
  • By Designation: C-level Executives: 27%, Directors: 18%, and Others: 55%
  • By Region: North America: 50%, Europe: 20%, APAC: 20%, and RoW: 10%

Key players in the molecular quality controls market include SeraCare Life Sciences Inc. (US), ZeptoMetrix Corporation (US), Bio-Rad Laboratories Inc. (US), Microbiologics Inc. (US), and Thermo Fisher Scientific (US). The study includes an in-depth competitive analysis of these key players in the molecular quality controls market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The market study covers the molecular quality controls market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, analyte type, application, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the revenue numbers for the overall molecular quality controls market and its subsegments. This report will help stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS COVERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY SOURCES
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY SOURCES
      • 2.1.2.1. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.3.1.1. Key industry insights

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION

4. PREMIUM INSIGHTS

  • 4.1. MOLECULAR QUALITY CONTROLS: MARKET OVERVIEW
  • 4.2. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT
  • 4.3. NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER (2018)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
    • 5.1.1. DRIVERS
      • 5.1.1.1. Increasing number of accredited clinical laboratories
      • 5.1.1.2. Growing adoption of third-party quality controls
      • 5.1.1.3. Rising demand for external quality assessment support
    • 5.1.2. RESTRAINTS
      • 5.1.2.1. Additional costs involved in quality control and budget constraints in hospitals and laboratories
      • 5.1.2.2. Unfavorable reimbursement scenario for molecular tests
    • 5.1.3. OPPORTUNITIES
      • 5.1.3.1. Rising demand for multi-analyte controls
    • 5.1.4. CHALLENGES
      • 5.1.4.1. Lack of mandatory regulations for clinical laboratory accreditation in several emerging countries
      • 5.1.4.2. Complex regulatory frameworks

6. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. INDEPENDENT CONTROLS
    • 6.2.1. WIDE RANGE OF APPLICATIONS AND REDUCTIONS IN OPERATIONAL COSTS HAVE BOOSTED THE USE OF INDEPENDENT CONTROLS
  • 6.3. INSTRUMENT-SPECIFIC CONTROLS
    • 6.3.1. PCR
      • 6.3.1.1. PCR controls dominate the instrument-specific controls market
    • 6.3.2. DNA SEQUENCING & NGS
      • 6.3.2.1. Advancements in sequencing technologies form a positive growth factor for this market
    • 6.3.3. OTHER TECHNOLOGIES

7. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE

  • 7.1. INTRODUCTION
  • 7.2. SINGLE-ANALYTE CONTROLS
    • 7.2.1. SIGNIFICANT USE OF SINGLEPLEX ASSAYS IN HOSPITALS-A KEY MARKET DRIVER
  • 7.3. MULTI-ANALYTE CONTROLS
    • 7.3.1. INCREASING PREFERENCE FOR MULTI-ANALYTE CONTROLS TO FUEL MARKET GROWTH

8. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. INFECTIOUS DISEASES
    • 8.2.1. DEMAND FOR INFECTIOUS DISEASE TESTING CONTROLS HAS GROWN STEADILY
  • 8.3. ONCOLOGY
    • 8.3.1. GROWING CANCER PREVALENCE AND TECHNOLOGICAL ADVANCEMENTS ARE KEY GROWTH DRIVERS IN THIS SEGMENT
  • 8.4. GENETIC TESTING
    • 8.4.1. ADVANCEMENTS IN GENETIC TESTING DRIVE THE MARKET
  • 8.5. OTHER APPLICATIONS

9. MOLECULAR QUALITY CONTROLS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. CLINICAL LABORATORIES
    • 9.2.1. INCREASING NUMBER OF ACCREDITED CLINICAL LABORATORIES TO PROVIDE GROWTH OPPORTUNITIES IN THE COMING YEARS
  • 9.3. HOSPITALS
    • 9.3.1. GROWING PATIENT VOLUME DRIVING THE ADOPTION OF MOLECULAR QUALITY CONTROLS IN HOSPITAL-BASED LABORATORIES
  • 9.4. IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS
    • 9.4.1. ADVANCEMENTS IN MOLECULAR TECHNOLOGIES DRIVING THE ADOPTION OF MOLECULAR QUALITY CONTROLS AMONG IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS
  • 9.5. ACADEMIC & RESEARCH INSTITUTES
    • 9.5.1. INCREASING DEMAND FOR ENSURING THE ACCURACY OF DIAGNOSTIC TESTS TO SUPPORT THE GROWTH OF THIS END-USER SEGMENT
  • 9.6. OTHER END USERS

10. MOLECULAR QUALITY CONTROLS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
      • 10.2.1.1. Increasing CLIA accreditation for clinical laboratories driving the market for molecular quality controls in the US
    • 10.2.2. CANADA
      • 10.2.2.1. Government investments supporting the development of advanced diagnostic procedures for infectious diseases and cancer in Canada
  • 10.3. EUROPE
    • 10.3.1. GROWING DEMAND FOR EXTERNAL QUALITY CONTROL SUPPORT FROM END USERS WILL PROVIDE GROWTH OPPORTUNITIES
  • 10.4. ASIA PACIFIC
    • 10.4.1. STRATEGIC DEVELOPMENTS BY LEADING PLAYERS TO DRIVE THE MARKET FOR MOLECULAR QUALITY CONTROLS IN APAC
  • 10.5. REST OF THE WORLD

11. COMPETITIVE LANDSCAPE

  • 11.1. MARKET OVERVIEW
  • 11.2. MARKET RANKING ANALYSIS, 2017
    • 11.2.1. COMPETITIVE LEADERSHIP MAPPING
    • 11.2.2. VISIONARY LEADERS
    • 11.2.3. INNOVATORS
    • 11.2.4. DYNAMIC DIFFERENTIATORS
    • 11.2.5. EMERGING COMPANIES
  • 11.3. COMPETITIVE BENCHMARKING
    • 11.3.1. STRENGTH OF PRODUCT PORTFOLIO (15 PLAYERS)
    • 11.3.2. BUSINESS STRATEGY EXCELLENCE (15 PLAYERS)

12. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, MnM View)*

  • 12.1. SERACARE LIFE SCIENCES INC.
  • 12.2. THERMO FISHER SCIENTIFIC
  • 12.3. BIO-RAD LABORATORIES
  • 12.4. MICROBIOLOGICS INC.
  • 12.5. ZEPTOMETRIX
  • 12.6. ROCHE DIAGNOSTICS
  • 12.7. ABBOTT LABORATORIES
  • 12.8. QUIDEL
  • 12.9. QNOSTICS
  • 12.10. MAINE MOLECULAR QUALITY CONTROLS INC.

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. AVAILABLE CUSTOMIZATIONS
  • 13.4. RELATED REPORTS
  • 13.5. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 2: INDEPENDENT CONTROLS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 3: NORTH AMERICA: INDEPENDENT CONTROLS MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 4: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 5: NORTH AMERICA: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 6: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 7: INSTRUMENT-SPECIFIC CONTROLS MARKET FOR PCR, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 8: NORTH AMERICA: INSTRUMENT-SPECIFIC CONTROLS MARKET FOR PCR, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 9: INSTRUMENT-SPECIFIC CONTROLS MARKET FOR DNA SEQUENCING & NGS, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 10: NORTH AMERICA: INSTRUMENT-SPECIFIC CONTROLS MARKET FOR DNA SEQUENCING & NGS, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 11: INSTRUMENT-SPECIFIC CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 12: NORTH AMERICA: INSTRUMENT-SPECIFIC CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 13: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2016-2024 (USD MILLION)
  • TABLE 14: SINGLE-ANALYTE CONTROLS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 15: NORTH AMERICA: SINGLE-ANALYTE CONTROLS MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 16: MULTI-ANALYTE CONTROLS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 17: NORTH AMERICA: MULTI-ANALYTE CONTROLS MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 18: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 19: MOLECULAR QUALITY CONTROLS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 20: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 21: MOLECULAR QUALITY CONTROLS MARKET FOR ONCOLOGY, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 22: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR ONCOLOGY, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 23: MOLECULAR QUALITY CONTROLS MARKET FOR GENETIC TESTING, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 24: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR GENETIC TESTING, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 25: MOLECULAR QUALITY CONTROLS MARKET FOR OTHER APPLICATIONS, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 26: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 27: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 28: MOLECULAR QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 29: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 30: MOLECULAR QUALITY CONTROLS MARKET FOR HOSPITALS, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 31: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 32: MOLECULAR QUALITY CONTROLS MARKET FOR IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 33: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 34: MOLECULAR QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 35: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 36: MOLECULAR QUALITY CONTROLS MARKET FOR OTHER END USERS, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 37: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 38: MOLECULAR QUALITY CONTROLS MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 39: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 40: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 41: NORTH AMERICA: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 42: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2016-2024 (USD MILLION)
  • TABLE 43: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 44: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 45: US: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 46: US: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 47: US: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2016-2024 (USD MILLION)
  • TABLE 48: US: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 49: US: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 50: CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 51: CANADA: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 52: CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2016-2024 (USD MILLION)
  • TABLE 53: CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 54: CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 55: EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 56: EUROPE: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 57: EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2016-2024 (USD MILLION)
  • TABLE 58: EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 59: EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 60: ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 61: ASIA PACIFIC: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 62: ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2016-2024 (USD MILLION)
  • TABLE 63: ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 64: ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2016-2024 (USD MILLION)
  • TABLE 65: ROW: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2016-2024 (USD MILLION)
  • TABLE 66: ROW: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2016-2024 (USD MILLION)
  • TABLE 67: ROW: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2016-2024 (USD MILLION)
  • TABLE 68: ROW: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 69: ROW: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2016-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: PRIMARY SOURCES
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2018 (USD MILLION)
  • FIGURE 7: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2018 VS. 2024 (USD MILLION)
  • FIGURE 8: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2018 (USD MILLION)
  • FIGURE 9: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2018
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE MOLECULAR QUALITY CONTROLS MARKET
  • FIGURE 11: MOLECULAR QUALITY CONTROLS MARKET TO REGISTER A DOUBLE-DIGIT GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 12: INDEPENDENT CONTROLS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2018-2024)
  • FIGURE 13: CLINICAL LABORATORIES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MOLECULAR QUALITY CONTROLS MARKET IN 2018
  • FIGURE 14: MOLECULAR QUALITY CONTROLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: NUMBER OF LABORATORIES THAT RECEIVED CLIA ACCREDITATION, BY ACCREDITATION ORGANIZATION (2018)
  • FIGURE 16: GEOGRAPHIC SNAPSHOT: APAC WILL BE THE FASTEST-GROWING REGIONAL SEGMENT IN THE MOLECULAR QUALITY CONTROLS MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • FIGURE 18: ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • FIGURE 19: RANK OF COMPANIES IN THE GLOBAL MOLECULAR QUALITY CONTROLS MARKET, 2017
  • FIGURE 20: MOLECULAR QUALITY CONTROLS MARKET (GLOBAL), COMPETITIVE LEADERSHIP MAPPING, 2017
  • FIGURE 21: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017)
  • FIGURE 22: BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2017)
  • FIGURE 23: ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2017)
  • FIGURE 24: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2017)
  • FIGURE 25: QUIDEL: COMPANY SNAPSHOT (2017)